Since 2010, VivoSense has been helping clinical researchers analyze and interpret wearable sensor data to improve patient research and care. We are innovating within the pharmaceutical clinical trial industry by developing new digital biomarkers using our proprietary VivoSense® software. Our mission is to realize the potential of novel measures and technologies in regulatory and medical decision-making to leverage real-world data at scale, bringing life-saving treatments to the patients who need them most. VivoSense closed a $25 Series A financing in March of 2022 to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments (COAs). VivoSense is committed to the development of better medicines and medical interventions for improved patient outcomes. VivoSense never tells the customer anything but the scientific truth, never promising what cannot be delivered. VivoSense is committed to diversity and inclusion, where every voice is heard and the best-reasoned facts are those acted upon. VivoSense strives for a minimal environmental impact, printing documents and traveling for business only when necessary.
Newport Beach, United States
Founded in 2010
11-50 Employees
Working industry
Biotechnology
Type of company
Service provider, Manufacturer
Ownership structure
Privately Held
Locations
1 Headquarter
Number of products
3 Products
Number of services
3 Services
Specialised areas
Respiratory monitoring, FDA, Biotechnology, Physiological software solutions, Heart Rate Variability, Cloud platform, Physiological monitoring, Physiological algorithm development, data analysis, Data visualization
VivoSense offers a wide range of products and services
Service
4 Key Principles of Digital Biomarker Development [eBook]
Go to product >
Product
The Value of Remote Monitoring in Decentralized Clinical Trials
Go to product >
Product
Oncology Research and Care: Reimagining Digital Innovation
Go to product >
Service
Example of New Digital Biomarker Development
Go to product >
Service
Digital Biomarkers for Alzheimer's Disease Drug Development
Go to product >
Product
Services
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
VivoSense operates in 1 country around the world
Get an overview of the locations of VivoSense
Location
Country
State
City
Headquarter
United States
California
Newport Beach
Some frequent questions that have been asked about VivoSense
Where is VivoSense located?
The company headquarter of VivoSense is located in Newport Beach, California, United States. It's worth noting, that the company may have more locations
How many employees does VivoSense approximately have?
As of the latest available information VivoSense has around 11-50 employees worldwide.
When was VivoSense founded?
VivoSense was founded in 2010
In which industries does VivoSense mainly work?
The company VivoSense has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to VivoSense
BioSensics
Watertown, United States
11-50 Employees
2007
BioSensics was founded in 2007 by three scientists from Harvard University with a vision of transforming the healthcare industry through innovative technologies. Since its establishment, BioSensics has created new paradigms in using wearable sensors in healthcare and revolutionized the medical alert industry by creating technologies that are now being used by thousands of older adults. BioSensics solutions encompass comprehensive and validated technologies for collection of digital biomarkers and outcome assessment in healthcare. We are hiring talented people in a variety of technical and nontechnical roles to join our outstanding team. BioSensics’ research and accelerated product commercialization strategy is cemented by partnerships and academic-industry collaborations. Mailing address:BioSensics LLC57 Chapel Street, Suite 200Newton, MA 02458.
Biosens
São Leopoldo, Brazil
1-10 Employees
2020
BIOSENS is a Brazilian deeptech company specialized in life sciences. Our biosensor-based technology represents a new frontier with the potential to transform laboratory diagnostics and healthcare. Biosensors are analytical devices that convert biological interactions and chemical reactions into measurable data. We develop reactive strips, each embedded with a biosensor, designed for specific analyses. Our goal is to decentralize laboratory diagnostic exams with accessible solutions that positively impact health professionals, researchers, and improves the patient journey. BIOSENS combines transdisciplinary knowledge and innovation, with proprietary technology, integrating areas such as cellular biology, genetics, artificial intelligence, advanced materials, CRISPR, bionanotechnology, the Internet of Things (IoT), microfabrication, and MEMS. This integration places BIOSENS at the technological forefront, in Brazil and worldwide, merging science and technology to revolutionize healthcare, transform patient experiences, improve quality of life, and contribute to a better world. We are dedicated to ensuring that every person can enjoy a healthier and more equitable future, eliminating barriers to a world where health is a priority and universal.
MediBioSense
Doncaster, United Kingdom
1-10 Employees
2015
Established in 2015, MediBioSense Ltd is a global multi-award-winning healthcare innovation company with a focus on medically certified wearable technologies. We are a UK-based company with global multi-national clients, including leading hospitals, big pharma, governments, healthcare providers, and the military, delivering our technology to over 40 countries around the world to date - and growing. MediBioSense is at the global forefront of medical wearable technologies. By providing wearable (medically approved) technology and integrated healthcare applications we are changing the way health is measured and tracked, transforming the global landscape of medical treatment. By providing wearable (medically approved) technology and integrated healthcare solutions we are changing the way health is measured and tracked and transforming the landscape of medical treatment. VitalPatch is a health-monitoring device in the growing field of Tele-Health. Never before has such a small, elegant device provided so much valuable information for physicians and nurses. This state-of-the-art biosensor monitors eight physiological measurements continuously, in real-time.
Virtusense Technologies, Inc.
Peoria, United States
11-50 Employees
2012
VirtuSense accelerates predictive insights allowing physicians, caregivers, and families to be proactive and patient-centric with Artificial Intelligence (AI) and innovative sensors. VirtuSense’s AI sensors detect movements and anomalies based on millions of hours of normative data to alert healthcare providers 30 - 65 seconds before a bed/chair exit occurs. Deepak founded VirtuSense to develop a tool that could proactively identify fall-risk in older adults. David Park joined VirtuSense first as a consultant, and later became our Chief Executive Officer. After launching VSTBalance, we developed our next product, VSTAlert. After a pursuit for answers, VirtuSense was born and rapidly became the solution for unpredictable falls nationwide. From there, the team began to grow as we built our support, sales, development, and marketing departments. The success of VSTAlert led the charge in launching our real-time monitoring product, VSTOne.
VivoSensMedical
Leipzig, Germany
11-50 Employees
2011
Die VivoSensMedical ist ein Medizintechnikunternehmen, das sich der Erforschung des Biomarkers Körperkerntemperatur verschrieben hat. Unser Ziel: Übersetzung von medizinischem Wissen in marktrelevante Medizinprodukte zur individuellen Diagnostik auf Basis des Biomarkers Körperkerntemperatur. Unsere Vision: Ein Paradigmenwechsel in der medizinischen Diagnostik – individuelle Diagnostik für bessere Therapien. Die VivoSensMedical wird durch den Europäischen Fonds für regionale Entwicklung (EFRE), durch das Sächsische Staatsministerium für Wirtschaft, Arbeit und Verkehr (SMWA), durch das Staatsministerium für Wissenschaft und Kunst (SMWK) sowie durch die Stadt Leipzig gefördert. Die VivoSensMedical GmbH wurde im Rahmen eines EXIST Gründerstipendiums vom Bundesministerium für Wirtschaft und Technologie unterstützt. Außerdem wird die VivoSensMedical mitfinanziert mit Steuermitteln auf Grundlage des vom Sächsischen Landtag beschlossenen Haushalt. Die VivoSensMedical GmbH verfügt über ein zertifiziertes Qualitätsmanagementsystem nach DIN EN ISO 13485. Diese übersetzen wir in medizinische Algorithmen und präzise sensorbasierte Medizinprodukte zur individuellen Diagnostik.
SENS Innovation ApS
Copenhagen, Denmark
1-10 Employees
2014
SENS Innovation ApS was founded in 2014 by Kasper L. The company develops medical sensor products, based on advanced sensor technology, for monitoring of physical activity with patients. The SENS products and platforms are easy to use, flexible, scalable and presents accurate monitoring of the body’s position and the nature of the activity, for both the individual or even larger groups. Therefore, SENS’s products and technology are a valuable tool in research trails to study e.g. SENS motion® is an integrated system for collecting physical activity data from groups of people. SENS motion® – For Healthcare enables the use of SENS motion activity sensor in healthcare environments, such as hospitals or care centres. It consists of a wireless activity sensor that automatically transfers data to a secure cloud. Do you want to build a wireless, scalable, battery-powered medical sensor or have a business opportunity where measurement of physical data is needed?